# A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma

> **NCT00001300** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 150 (—)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** doxorubicin
- **DRUG:** ifosfamide
- **DRUG:** mesna

## Key facts

- **NCT ID:** NCT00001300
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-06
- **Primary completion:** —
- **Final completion:** 2001-03
- **Target enrollment:** 150 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001300, "A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00001300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*